Matches in Nanopublications for { ?s ?p "[To evaluate the effect of excision repair cross-complementing group 1 (ERCC1) and X-ray cross-complementing group 1 (XRCC1) gene polymorphisms on treatment outcome in patients receiving oxaliplatin-based regimens for metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_assertion description "[To evaluate the effect of excision repair cross-complementing group 1 (ERCC1) and X-ray cross-complementing group 1 (XRCC1) gene polymorphisms on treatment outcome in patients receiving oxaliplatin-based regimens for metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_provenance.
- NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_assertion description "[To evaluate the effect of excision repair cross-complementing group 1 (ERCC1) and X-ray cross-complementing group 1 (XRCC1) gene polymorphisms on treatment outcome in patients receiving oxaliplatin-based regimens for metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_provenance.
- NP59382.RAeqiGCZYqTXISgIDdWr7txItFVtPTkNXlVyF-Uyp5mZs130_assertion description "[To evaluate the effect of excision repair cross-complementing group 1 (ERCC1) and X-ray cross-complementing group 1 (XRCC1) gene polymorphisms on treatment outcome in patients receiving oxaliplatin-based regimens for metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59382.RAeqiGCZYqTXISgIDdWr7txItFVtPTkNXlVyF-Uyp5mZs130_provenance.